WPRIM Management System> DCMS> Chinese Journal of Urology> 2022> 43> 6

Volume: 43 Issue: 6

1. Multimodality bladder-sparing treatment options for muscle-invasive bladder cancer Page:407—410
2. Bladder-sparing treatment following noninvasive down-staging after transurethral resection of bladder tumor plus systemic chemotherapy for muscle-invasive bladder cancer Page:411—415
3. The safety and efficacy of trimodality treatment for invasive bladder cancer Page:416—422
4. Clinical characteristics and prognostic analysis of renal primary neuroendocrine neoplasms Page:423—429
5. Efficacy and safety of docetaxel plus hormone therapy in metastatic prostate cancer Page:430—435
6. Safety and efficacy of individualized transperineal prostate biopsy based on the segmentation of PI-RADS version 2 for mpMRI Page:436—440
7. The relationship between the serum markers and bone metastasis of initial diagnosed prostate cancer patients in different ISUP groups Page:441—446
8. Preliminary experience of flexible vacuum-assisted ureteral access sheath(FV-UAS) in retrograde intrarenal lithotripsy Page:447—450
9. Diagnosis and treatment analysis of renal pelvic hemangioma Page:451—452
10. Safety and efficacy of 980nm diode laser in the treatment of scrotal angiokeratoma Page:453—454
11. Totally intracorporeal robot-assisted orthotopic ileal neobladder after bladder preservation therapy: a case report Page:455—457
12. A case report of bladder clear cell carcinoma Page:458—459
13. Adenocarcinoma of the rete testis: a case report Page:460—461
14. Ectopic salivary glands in the urogenital system: a case report Page:462—463
15. Advances in the comprehensive treatment of muscle-invasive bladder cancer with preservation of the bladder Page:464—468
16. Research advances of urinary cell-free DNA in the detection and therapy of bladder cancer Page:469—472
17. Research progress of engineered nanomaterials in the diagnosis and treatment of prostate cancer Page:473—476
18. Diagnosis and treatment of genetically related urinary calculi Page:477—480